Windlas Biotech is currently trading at Rs. 269.85, up by 33.60 points or 14.22% from its previous closing of Rs. 236.25 on the BSE.
The scrip opened at Rs. 246.00 and has touched a high and low of Rs. 280.00 and Rs. 241.40 respectively. So far 14834 shares were traded on the counter.
The BSE group 'B' stock of face value Rs. 5 has touched a 52 week high of Rs. 452.10 on 16-Aug-2021 and a 52 week low of Rs. 208.90 on 31-Mar-2022.
Last one week high and low of the scrip stood at Rs. 280.00 and Rs. 235.00 respectively. The current market cap of the company is Rs. 594.22 crore.
The promoters holding in the company stood at 59.95%, while Institutions and Non-Institutions held 15.07% and 24.99% respectively.
Windlas Biotech has received certificate of Good Manufacturing Practices (GMP) from SAHPRA (South African Health Products Regulatory Authority). The company had undergone the inspection audit from September 20 to 29, 2021.
Windlas Biotech is into domestic pharmaceutical formulations contract development and manufacturing business.
